For a 45‑year‑old woman at 35 weeks gestation undergoing scheduled cesarean delivery with BMI 31 (obesity) and no other venous thromboembolism risk factors, what venous thromboembolism prophylaxis (pharmacologic and mechanical) is indicated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

VTE Prophylaxis for Scheduled Cesarean Delivery in 45-Year-Old Obese Woman

This patient requires combined mechanical and pharmacologic thromboprophylaxis with sequential compression devices plus enoxaparin 40 mg subcutaneously once daily, making option A (Enoxaparin and compression socks) the correct answer. 1, 2

Risk Stratification

This patient has two minor risk factors that together elevate her VTE risk above the 3% threshold requiring pharmacologic prophylaxis:

  • Advanced maternal age (45 years): Classified as a minor risk factor by ACCP guidelines 1, 2
  • Class I obesity (BMI 31): Represents a minor risk factor for VTE 1, 2
  • Scheduled cesarean delivery: Inherently increases VTE risk 4-fold compared to vaginal delivery 3

The American College of Chest Physicians explicitly states that the presence of at least two minor risk factors indicates VTE risk exceeding 3%, warranting pharmacologic thromboprophylaxis 1, 2. The combination of age ≥35 years and obesity creates a cumulative risk profile that mandates intervention beyond early ambulation alone 4.

Recommended Prophylaxis Strategy

Mechanical Prophylaxis (Universal Requirement)

All women undergoing cesarean delivery must receive sequential compression devices starting before surgery and continuing until fully ambulatory, regardless of additional risk factors (GRADE 1C recommendation) 1, 2. This is non-negotiable and applies even to low-risk patients 1.

Pharmacologic Prophylaxis (Required for This Patient)

Enoxaparin 40 mg subcutaneously once daily is the preferred agent for this patient with Class I obesity (BMI 31) 2. The Society for Maternal-Fetal Medicine and ACOG recommend prophylactic low-molecular-weight heparin for women with one major or at least two minor risk factors 1, 2.

Important dosing distinction: Standard prophylactic dosing (40 mg once daily) is appropriate for BMI 31 2. Intermediate-dose enoxaparin (40 mg every 12 hours) is reserved for Class III obesity (BMI ≥40), which does not apply to this patient 2.

Duration of Prophylaxis

  • Mechanical prophylaxis: Continue until fully ambulatory 1, 2
  • Pharmacologic prophylaxis: Consider extension up to 6 weeks postpartum if risk factors persist (Grade 2C) 1, 2

Why Other Options Are Incorrect

Option B (Continue vitamins, no prophylaxis): This approach ignores established guidelines and would be appropriate only for women with zero risk factors undergoing cesarean delivery 1. The ACCP explicitly recommends no prophylaxis other than early mobilization only when no risk factors are present 1. This patient's age and obesity disqualify her from this low-risk category 2, 4.

Option C (Early ambulation alone): While early mobilization is recommended for all patients, it is insufficient as sole prophylaxis when two or more minor risk factors are present 1. The ACCP guidelines clearly state that early mobilization alone is appropriate only for women without risk factors 1.

Option D (Antiplatelets with aspirin): Aspirin has no role in VTE prophylaxis for cesarean delivery 1. Antiplatelet agents do not prevent venous thromboembolism; low-molecular-weight heparin is the evidence-based pharmacologic agent 2.

Critical Implementation Details

  • Timing of enoxaparin initiation: Begin 12 hours after neuraxial block (or 4 hours after epidural catheter removal if using standard prophylactic dosing) 2
  • Contraindication screening: Verify creatinine clearance >30 mL/min; if lower, use unfractionated heparin instead 2
  • Institutional protocol: SMFM recommends standardized VTE prophylaxis bundles for all cesarean delivery patients (Best Practice) 1, 2

Common Pitfalls to Avoid

Do not underestimate cumulative risk: The combination of advanced maternal age and obesity creates a multiplicative effect that mandates intervention 4. Each factor alone might seem modest, but together they cross the threshold for pharmacologic prophylaxis 1, 2.

Do not delay mechanical prophylaxis: Sequential compression devices must be applied before surgery, not after the patient reaches the postpartum unit 1.

Do not use compression stockings alone: While the question mentions "compression socks," the evidence specifically supports sequential compression devices (pneumatic compression), which are more effective than static elastic stockings 1.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

VTE Prophylaxis for Cesarean Section

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Complications in Pregnancy with Advanced Maternal Age and Obesity

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What is the recommended VTE prophylaxis for a 45-year-old pregnant female at 35 weeks gestational age, scheduled for a cesarean section, with a BMI of 31 and no history of DVT or coagulopathy?
What contraception options are suitable for a post-cesarean delivery woman with obesity, weighing 128kg, and potentially other comorbidities such as hypertension and diabetes?
Do you withhold anticoagulants in a pregnant patient with vaginal hemorrhage and Pulmonary Embolism (PE)?
Should pulmonary embolism (PE) be considered in the presence of vaginal bleeding?
What are the key anaesthetic concerns for a 40-year-old obese (Body Mass Index (BMI) of 38 kg/m²) woman undergoing an emergency lower segment caesarean section due to acute fetal distress?
What is the recommended long‑term follow‑up and management plan for an adult with traumatic paraplegia who underwent a laminectomy three years ago?
What is the recommended prophylaxis for tumor lysis syndrome in a high‑risk patient (e.g., high tumor burden, rapidly proliferating hematologic malignancy, elevated LDH or uric acid, or renal impairment) before initiating cytotoxic therapy?
What causes early hair loss and what are the first‑line management options?
What oral antibiotic is recommended for an adult with uncomplicated cystitis that is resistant to nitrofurantoin (Macrobid) and ciprofloxacin?
What are the approved and off‑label uses, dosing regimens, contraindications, and alternative therapies for bupropion (including Zyban)?
What are the mechanisms that cause hypoalbuminemia in sepsis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.